Hyunju Lee
Endocrinology, Diabetes & Metabolism · Anaheim, CANPI 1629483102
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.
Across 65 payments — averaging $25.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$245
- Novartis$226
- Novo Nordisk$173
- Boehringer Ingelheim$145
- Lilly USA, LLC$88
- Averitas Pharma Inc.$84
- plus $670 from 18 others
What the payments were for
- Food & beverage$1,630100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $245 |
| Novartis | 9 | $226 |
| Novo Nordisk | 5 | $173 |
| Boehringer Ingelheim | 5 | $145 |
| Lilly USA, LLC | 3 | $88 |
| Averitas Pharma Inc. | 3 | $84 |
| Neurocrine Biosciences, Inc. | 2 | $73 |
| Corcept Therapeutics | 3 | $70 |
| Recordati_rare_diseases_inc. | 2 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Insulet Corporation | 2 | $56 |
| Mannkind Corporation | 2 | $40 |
| Medtronic | 1 | $35 |
| IBSA Pharma Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $34 |
| AstraZeneca | 1 | $31 |
| Sequel Med Tech, LLC | 1 | $28 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Tolmar, Inc. | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$117
How this compares
$1,630 in reported general payments places this provider in the 55th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in Anaheim
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
- Daniel Einhornla Jolla$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.